Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Follow-up Repeat glucose and CMP-related markers after 4-12 weeks or sooner if vomiting, dehydration, or glucose symptoms occur
and a combined form in which both junctional and nodular patterns occur [15, 55, 56]
Another advantage is the cost
Further characterization of the human commensals capable of both reactions (l-carnitineBB and BBTMA), and discovery of the enzyme(s) responsible for TMA production, are of interest particularly since this latter microbial step in the overall pathway appears to be the major one induced during chronic dietary red meat exposure (or directly with l-carnitine supplementation) in an omnivorous diet (Figure 10)